NCCN Guidelines for Patients® | Myeloproliferative Neoplasms

40 NCCN Guidelines for Patients ® : Myeloproliferative Neoplasms, 2018 4 Polycythemia vera Review Review † † PV is commonly found after a blood test that was given for another reason. A key feature of PV is a high number of red blood cells. † † Treatment options are based on risk for blood clots. Aspirin to control symptoms is an option for all risk groups. Phlebotomy may be received to reduce hematocrit. For high-risk PV, cytoreductive treatment may be an option to reduce blood counts. † † You will need to meet with your doctor often. He or she will assess the status of the cancer and how you feel. † † If the cancer is getting worse, you may receive another type of cytoreductive treatment. Ruxolitinib and joining a clinical trial are other options. I was diagnosed with PV when I was 57 years old. Now I am 68. Most of the time my disease has been under control. –Gail Survivor, Polycythemia vera “